AptarGroup, Inc. Q1 2007 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2007. AptarGroup, Inc. is a global manufacturer of packaging components, specifically dispensing systems for the personal care, fragrance/cosmetic, household, pharmaceutical, and food/beverage markets. The company operates through three primary segments: Beauty & Home, Closures, and Pharma.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Net Sales | $449.8 million | $375.5 million |
| Operating Income | $46.6 million | $32.4 million |
| Net Income | $29.6 million | $19.8 million |
| Diluted EPS | $0.82 | $0.55 |
| Operating Margin | 10.4% | 8.6% |
| Cash Flow from Operations | $34.2 million | $31.5 million |
| Cash and Equivalents (End of Period) | $181.2 million | $120.2 million |
| Total Debt (Short & Long Term) | $313.3 million | $296.3 million (Dec 31, 2006) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 20% year-over-year. Approximately 6% of this growth was driven by favorable foreign exchange rates (weaker U.S. dollar vs. Euro), 2% by acquisitions, and the remaining 12% by increased organic demand.
- Profitability: Operating income rose 44% to $46.6 million. The operating margin expanded to 10.4% from 8.6%, aided by the leveraging of fixed manufacturing costs and a favorable product mix (decreased low-margin custom tooling sales).
- Cost Pressures: Cost of sales as a percentage of net sales improved to 66.7% from 67.6%. However, rising raw material costs (specifically nickel) negatively impacted costs by over $1 million, and currency fluctuations added approximately $1 million to costs.
- Acquisitions: The company acquired Moderne Verpackungssysteme GmbH (MVS) in Germany for approximately $5.2 million in cash on February 15, 2007.
- Share Repurchases: The company repurchased 182,000 shares for $11.9 million during the quarter.
Guidance, Outlook, and Risks
- Q2 2007 Guidance: Management anticipates diluted earnings per share (pre-split) in the range of $0.96 to $1.01 for the second quarter of 2007, compared to $0.77 in the prior year.
- Sales Outlook: Sales are expected to remain strong in Q2, with continued positive impact from the weak U.S. dollar. The Pharma segment is expected to improve further, while Beauty & Home and Closures segments are projected to increase over the prior year.
- Cost Risks: Raw material costs, particularly nickel surcharges, are expected to rise in Q2. The company faces the risk of not being able to pass these costs to customers quickly enough.
- Stock Split: A two-for-one stock split was approved on April 18, 2007, to be distributed on May 9, 2007. Historical per-share data will be restated in future filings.
- Dividend: The quarterly dividend was increased 18% to $0.26 per share.
- Key Risks: Significant fluctuations in currency exchange rates, raw material availability and cost (resin, metal, nickel), competition from Asia, and the ability to successfully integrate acquisitions.
Investor Verification Checklist
- Verify the impact of rising nickel prices on future gross margins and the company's ability to implement price increases.
- Monitor the integration progress and financial contribution of the MVS acquisition.
- Confirm the timing and tax implications of the repatriation of approximately $10 million in foreign earnings.
- Review the effectiveness of hedging strategies given the company's significant exposure to the Euro and other foreign currencies.
- Track the execution of the workforce redeployment program in France and associated cost savings.